World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
35302
World Ranking
2265
National Ranking
1096

Medicine

D-Index
72
Citations
35555
World Ranking
19747
National Ranking
9835

Naomi F. Rothfield publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Naomi F. Rothfield sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Naomi F. Rothfield D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Naomi F. Rothfield sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Naomi F. Rothfield was affiliated with the University of Connecticut in the United States during their academic career. Their contributions to medical and scientific research were recognized within professional circles, as reflected by their membership in the Association of American Physicians.

While detailed records of their research publications, coauthors, and frequent publication venues are not available, this scientist's career was distinguished by involvement in advancing knowledge within their field.

There is no information on specific research papers, book publications, or detailed topics of study related to Naomi F. Rothfield. However, their association with a major research university suggests active participation in academic and clinical research activities.

Their status as deceased indicates that their work belongs to a previous era of scientific investigation, but the acknowledgment by a recognized medical association confirms a level of professional engagement and recognition during their lifetime.

Best Publications

  • The 1982 revised criteria for the classification of systemic lupus erythematosus

    Eng M. Tan;Alan S. Cohen;James F. Fries;Alfonse T. Masi

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Range of antinuclear antibodies in "healthy" individuals

    E. M. Tan;T. E. W. Feltkamp;J. S. Smolen;B. Butcher

  • Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma.

    William C. Earnshaw;Naomi Rothfield

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen

    William C. Earnshaw;Kevin E Sullivan;Paula S. Machlin;Carol A. Cooke

  • CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate

    Hisato Saitoh;John Tomkiel;Carol A. Cooke;Harry Ratrie

  • High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients.

    JH Shero;B Bordwell;NF Rothfield;WC Earnshaw

  • Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

    Peter A. Merkel;Peter A. Merkel;Karen Herlyn;Richard W. Martin;Jennifer J. Anderson

  • Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

    James R. Seibold;Joseph H. Korn;Robert Simms;Phillip J. Clements

  • The Clinical Course of the Proliferative and Membranous Forms of Lupus Nephritis

    David S. Baldwin;Jerome Lowenstein;Naomi F. Rothfield;Gloria Gallo

  • cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment

    Peter D'Arpa;Paula S. Machlin;Harry Ratrie;Naomi F. Rothfield

  • Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.

    E S Weiner;W C Earnshaw;J L Senécal;B Bordwell

  • Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

    W Earnshaw;B Bordwell;C Marino;N Rothfield

  • Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.

    Matthew D. Linnik;Jay Z. Hu;Kenneth R. Heilbrunn;Vibeke Strand

  • Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study

    Fredrick M. Wigley;Joseph H. Korn;M. E. Csuka;Thomas A. Medsger

  • Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.

    Megan E. B. Clowse;Daniel J. Wallace;Richard A. Furie;Michelle A. Petri

  • Lupus erythematosus: systemic and cutaneous manifestations

    Naomi Rothfield;Richard D. Sontheimer;Megan Bernstein

  • Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial

    Mario H. Cardiel;James A. Tumlin;Richard A. Furie;Daniel J. Wallace

  • A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.

    Eng M. Tan;Josef S. Smolen;J. S. McDougal;Brian T. Butcher

  • Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's disease. A prospective study.

    E S Weiner;S Hildebrandt;J L Senécal;L Daniels

  • Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus: Results of a multicenter randomized, double-blind, placebo-controlled trial

    Michelle A. Petri;Philip J. Mease;Joan T. Merrill;Robert G. Lahita

  • Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a Systemic Sclerosis Clinical Trial

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Grace S. Park

Frequent Co-Authors

William C. Earnshaw
William C. Earnshaw University of Edinburgh
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Virginia D. Steen
Virginia D. Steen Georgetown University
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Larry W. Moreland
Larry W. Moreland University of Colorado Anschutz Medical Campus
Peter A. Merkel
Peter A. Merkel University of Pennsylvania
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Fredrick M. Wigley
Fredrick M. Wigley Johns Hopkins University
John Varga
John Varga University of Michigan–Ann Arbor
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open up diverse career opportunities in healthcare and research. Nursing roles, especially nurse practitioner programs, offer accessible pathways for professionals looking to specialize. Many students seek out the easiest NP programs to get into as a way to start their advanced clinical training with fewer admissions barriers.

Specializations such as psychiatric-mental health nurse practitioner (PMHNP) programs are valuable for those focused on mental health immunology intersections. The best PMHNP programs offer robust clinical placement rates, ensuring hands-on experience which is crucial for career advancement.

Cost is also a major consideration. Many learners turn to the cheapest online PMHNP certificate programs to gain credentials without incurring significant debt. These affordable options provide quality education while easing financial burdens.

Professionals with advanced degrees like a Doctor of Nursing Practice (DNP) often secure higher salaries. Understanding the highest paid DNP specialties can help guide those in immunology or related fields toward the most lucrative roles. Combining immunology knowledge with advanced nursing credentials can lead to impactful and well-compensated career paths.

Best Scientists Citing Naomi F. Rothfield

Recently Published Articles